Join to View Full Profile
333 Cedar St# 205New Haven, CT 06510
Phone+1 203-785-4095
Fax+1 203-785-4116
Dr. Aguirre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2023 - 2025- Harvard School of Public HealthPCE, 2023 - 2024
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
University of Miami Hospital and Clinics/Holy Cross HospitalResidency, Internal Medicine, 2017 - 2020
Universidad Catolica de Santiago de GuayaquilClass of 2013
Certifications & Licensure
MA State Medical License 2023 - Present
CT State Medical License 2025 - 2027
FL State Medical License 2017 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.Luis E Aguirre, Jan Philipp Bewersdorf, Yiwen Liu, Rory M Shallis, Leora Boussi
Blood Neoplasia. 2026-05-01 - Hypomethylating agents plus venetoclaxintensive chemotherapy prior to transplant in high-risk acute myeloid leukemia.Guillaume Berton, Jan Philipp Bewersdorf, Julia Gilhodes, Alexandre Iat, Amel Soua
Haematologica. 2026-04-02 - Hypomethylating agents plus venetoclax versus intensive chemotherapy in acute myeloid leukemia with chromosome 5 and 7 abnormalities.Leora Boussi, Jan Philipp Bewersdorf, Yiwen Liu, Rory M Shallis, Luis E Aguirre
Haematologica. 2026-01-29
Abstracts/Posters
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceLuis E. Aguirre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceLuis E. Aguirre, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Portuguese, French, German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
